Movement Alert|Teradyne Rises 3.24% Overnight, Q2 Earnings Significantly Beat Expectations with Strong Q3 Guidance

Market Focus07-30

On July 30, Teradyne rose 3.24% overnight, trading at $329.77/share, with turnover of $448,900. The stock continued its upward momentum following a blowout Q2 earnings report and robust Q3 guidance that far exceeded Wall Street consensus.

Teradyne reported Q2 adjusted EPS of $2.47, beating the analyst estimate of $2.09 by 18%. Revenue reached $1.33 billion, up 104% year-over-year, surpassing the expected $1.22 billion. The semiconductor test segment contributed $1.122 billion, driven by surging AI chip testing demand. Net income soared to $374.5 million from $78.4 million in the year-ago period.

Q3 guidance was equally impressive, with revenue projected at $1.2 billion to $1.3 billion versus the Street estimate of $1.06 billion, and adjusted EPS guidance of $1.85 to $2.15 (midpoint $2.00) well above the consensus of $1.44. Multiple investment banks have raised price targets, with Cantor Fitzgerald lifting to $550, UBS to $500, JPMorgan to $450, and Goldman Sachs to $465, reflecting strong institutional confidence in AI-driven growth sustainability.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment